Document Detail


Health care index score and risk of death following tuberculosis diagnosis in HIV-positive patients.
MedLine Citation:
PMID:  23317955     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
OBJECTIVES: To assess health care utilisation for patients co-infected with TB and HIV (TB-HIV), and to develop a weighted health care index (HCI) score based on commonly used interventions and compare it with patient outcome.
METHODS: A total of 1061 HIV patients diagnosed with TB in four regions, Central/Northern, Southern and Eastern Europe and Argentina, between January 2004 and December 2006 were enrolled in the TB-HIV study. A weighted HCI score (range 0-5), based on independent prognostic factors identified in multivariable Cox models and the final score, included performance of TB drug susceptibility testing (DST), an initial TB regimen containing a rifamycin, isoniazid and pyrazinamide, and start of combination antiretroviral treatment (cART).
RESULTS: The mean HCI score was highest in Central/Northern Europe (3.2, 95%CI 3.1-3.3) and lowest in Eastern Europe (1.6, 95%CI 1.5-1.7). The cumulative probability of death 1 year after TB diagnosis decreased from 39% (95%CI 31-48) among patients with an HCI score of 0, to 9% (95%CI 6-13) among those with a score of ≥4. In an adjusted Cox model, a 1-unit increase in the HCI score was associated with 27% reduced mortality (relative hazard 0.73, 95%CI 0.64-0.84).
CONCLUSIONS: Our results suggest that DST, standard anti-tuberculosis treatment and early cART may improve outcome for TB-HIV patients. The proposed HCI score provides a tool for future research and monitoring of the management of TB-HIV patients. The highest HCI score may serve as a benchmark to assess TB-HIV management, encouraging continuous health care improvement.
Authors:
D N Podlekareva; D Grint; F A Post; A Mocroft; A M Panteleev; R F Miller; J M Miro; M Bruyand; H Furrer; V Riekstina; E Girardi; M H Losso; J A Caylá; E A Malashenkov; N Obel; A M Skrahina; J D Lundgren; O Kirk;
Related Documents :
24526225 - Identifying and characterizing places for the targeted control of heterosexual hiv tran...
24178755 - Risk of pancreatic cancer among individuals with hepatitis c or hepatitis b virus infec...
24032045 - Efficacy and safety of telbivudine compared to entecavir among hbeag+ chronic hepatitis...
8033925 - Niemann-pick-like liver disease and reduced cholesterol esterification in fibroblasts o...
23093975 - Recurrent posterior reversible encephalopathy syndrome potentially related to aids and ...
22798215 - Hiv prevention interventions to reduce racial disparities in the united states: a syste...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease     Volume:  17     ISSN:  1815-7920     ISO Abbreviation:  Int. J. Tuberc. Lung Dis.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9706389     Medline TA:  Int J Tuberc Lung Dis     Country:  France    
Other Details:
Languages:  eng     Pagination:  198-206     Citation Subset:  IM    
Affiliation:
Copenhagen HIV Programme, University of Copenhagen, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Safety and effectiveness of HAART in tuberculosis-HIV co-infected patients in Brazil.
Next Document:  Effectiveness of active case-finding strategies in tuberculosis control in Kampala, Uganda.